David Topper - Apr 10, 2024 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: Chief Financial Officer
Signature: /s/ Masaru Matsuda, Attorney-on-Fact for David Topper
Stock symbol: ARQT
Transactions as of: Apr 10, 2024
Transactions value $: $0
Form type: 4
Date filed: 4/11/2024, 08:32 PM
Previous filing: Nov 23, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARQT	Common Stock	Award	$0	+110K		$0.00	110K	Apr 10, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARQT	Stock Option (right to buy)	Award	$0	+310K		$0.00	310K	Apr 10, 2024	Common Stock	310K	$12.34	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs") that will vest as to 25% of the RSUs on each annual anniversary of April 10, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
F2	The option will vest and become exercisable as to 25% of the shares on the first annual anniversary of the grant date of April 10, 2024, and the remaining options will vest at 2.0833%, on each monthly anniversary thereafter, subject to the Reporting Person's continued service through the applicable vesting date.